We serve Chemical Name:(3-Chloropyridin-4-yl)methanol CAS:79698-53-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(3-Chloropyridin-4-yl)methanol
CAS.NO:79698-53-6
Synonyms:3-Chloro-4-pyridinemethanol;4-Pyridinemethanol, 3-chloro-;(3-Chloro-4-pyridinyl)methanol;4-Pyridinemethanol,3-chloro;(3-Chloropyridin-4-yl)methanol
Molecular Formula:C6H6ClNO
Molecular Weight:143.571
HS Code:2933399090
Physical and Chemical Properties:
Melting point:114-115℃
Boiling point:261.0±25.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.572
PSA:33.12000
Exact Mass:143.013794
LogP:0.39
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Chloro-4-pyridinemethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3-Chloropyridin-4-yl)methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-Chloro-4-pyridinyl)methanol Use and application,(3-Chloropyridin-4-yl)methanol technical grade,usp/ep/jp grade.
Related News: According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. 3-(3-chloro-5-fluorophenyl)-1-[3-(trifluoromethyl)phenyl]propan-1-one manufacturers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. 4-hydroxy-3-methyl-2-pent-4-enyl-cyclopent-2-enone suppliers Jan Vertommen, Senior Director, Commercial Development, Lonza, said, “Increasing our capabilities by adding mid-scale API manufacturing at our site in Nansha will benefit our customers, and especially the many global emerging biotech companies we partner with. (2-chlorophenyl)-[3-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)phenyl]methanone vendor & factory According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug.,According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people,
